Fig. 5From: Identification of potential therapeutic targets for atherosclerosis by analysing the gene signature related to different immune cells and immune regulators in atheromatous plaquesComparison of the expression of genes related to different immune regulators in GSE100927. ns: p > 0.05, *p <  = 0.05, **p  ≤ 0.01, ***p  ≤ 0.001, ****p  ≤ 0.0001. 80 genes were detected in GSE100927. A–E were a set of comparisons between atheromatous plaques and healthy control: A box plot comparing the expression of human leukocyte antigen (HLA)-related genes, B immune checkpoint-related genes, C IFN-γ pathway marker genes, D m6A methylation regulator-related genes, E circadian rhythm-related genes. F–J were a set of comparisons between atheromatous plaques in the ImmuneScoreH cluster with that in atheromatous plaques in the ImmuneScoreL cluster: F Box plot comparing the expression of HLA-related genes, G immune checkpoint-related genes, H IFN-γ pathway marker genes, I m6A methylation regulator-related genes, J circadian rhythm-related genes. K Summarized the consistent results between the two sets of comparisons (atheromatous plaques vs. healthy controls/ImmunceScoreH cluster vs. ImmunceScoreL cluster)Back to article page